🕵️ Drugs MADE In America Acquisition Corp. ($DMAAU)
SEC insider & ownership activity, last 12 months · CIK 2028614 · every row links its SEC filing
Insiders were quiet over the last 12 months – no open-market buys or sells. No red-flag 8-Ks in the window.
Insider flow
0 buyers, $0 (0 lots) · 0 sellers, $0 (0 lots)
No open-market insider transactions in the last 12 months.
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Lynn Stockwell | 12.5% | 13D | Feb 18, 2025 | filing ↗ | |
| Drugs MADE In America Acquisition LLC | 12.5% | 13D | Feb 18, 2025 | filing ↗ | |
| Karpus Management, Inc. | 10.3% | 13G | Aug 14, 2026 | filing ↗ | |
| Mizuho Financial Group, Inc. | 8.5% | 13G | Aug 13, 2026 | filing ↗ | |
| Polar Asset Management Partners Inc. | 5.7% | 13G | May 15, 2025 | filing ↗ | |
| FEIS Equities LLC | 5.1% | 13G | Jun 26, 2026 | filing ↗ | |
| Lawrence M. Feis | 5.1% | 13G | Jun 26, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Material agreement (1.01) | Sep 8, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 8, 2026 | filing ↗ |
| Material agreement (1.01) | Jul 14, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 14, 2026 | filing ↗ |
| Material agreement (1.01) | Apr 29, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 29, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Apr 27, 2026 | filing ↗ |
| Shareholder vote (5.07) | Apr 27, 2026 | filing ↗ |
| Other events (8.01) | Apr 27, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 27, 2026 | filing ↗ |
| Material agreement (1.01) | Apr 22, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 22, 2026 | filing ↗ |
| Other events (8.01) | Apr 7, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 7, 2026 | filing ↗ |
| Material agreement (1.01) | Mar 23, 2026 | filing ↗ |
| New financial obligation (2.03) | Mar 23, 2026 | filing ↗ |
| Other events (8.01) | Mar 23, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 23, 2026 | filing ↗ |
| Other events (8.01) | Mar 6, 2026 | filing ↗ |
| Officer/director changes (5.02) | Feb 28, 2026 | filing ↗ |
| Officer/director changes (5.02) | Oct 8, 2025 | filing ↗ |